BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3470449)

  • 1. Induced hypotension with labetalol for orthognathic surgery.
    McNulty S; Sharifi-Azad S; Farole A
    J Oral Maxillofac Surg; 1987 Apr; 45(4):309-11. PubMed ID: 3470449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of labetalol and nitroprusside for inducing hypotension during major surgery.
    Goldberg ME; McNulty SE; Azad SS; Cantillo J; Torjman M; Marr AT; Huffnagle S; Seltzer JL
    Anesth Analg; 1990 May; 70(5):537-42. PubMed ID: 2082945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol attenuates the negative effects of deliberate hypotension induced by isoflurane.
    Toivonen J; Virtanen H; Kaukinen S
    Acta Anaesthesiol Scand; 1992 Jan; 36(1):84-8. PubMed ID: 1539484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.
    Kaufman L
    Br J Clin Pharmacol; 1979; 8(Suppl 2):229S-232S. PubMed ID: 526406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nitroglycerin versus labetalol on peripheral perfusion during deliberate hypotension for sinus endoscopic surgery: a randomized, controlled, double-blinded trial.
    Zayed M; Nassar H; Hasanin A; Saleh AH; Hassan P; Saad D; Mahmoud S; Abo Bakr G; Fouad E; Saleh N; Ismail M; El-Hadi H
    BMC Anesthesiol; 2020 Apr; 20(1):85. PubMed ID: 32303182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of labetalol-induced controlled hypotension during middle ear microsurgery.
    De Hert S; Boeckx E; Vercauteren M; Claes J; Van den Heyning P; Adriaensen H
    Acta Otorhinolaryngol Belg; 1989; 43(2):157-62. PubMed ID: 2603701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of labetalol as a moderate hypotensive agent in otological operations--plasma concentrations after intravenous administration.
    Kanto J; Pakkanen A; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):191-4. PubMed ID: 7390669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deliberate hypotension induced by labetalol on renal function.
    Toivonen J; Kaukinen S; Oikkonen M; Hannelin M
    Eur J Anaesthesiol; 1991 Jan; 8(1):13-20. PubMed ID: 1874198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of labetalol-induced hypotension in the anaesthetized dog.
    Gustafson C; Ahlgren I; Aronsen KF; Rosberg B
    Br J Anaesth; 1981 Jun; 53(6):585-90. PubMed ID: 7248122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol in controlled hypotension: administration of labetalol when adequate hypotension is difficult to achieve.
    Cope DH; Crawford MC
    Br J Anaesth; 1979 Apr; 51(4):359-65. PubMed ID: 465259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of labetalol in severe hypertension.
    Omvik P; Lund-Johansen P
    J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulatory effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Littlewood DG; Macrae WR; Arthur GR; Drummond GB
    Anaesthesia; 1978 Feb; 33(2):145-56. PubMed ID: 637271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
    Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
    Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deliberate hypotensive anesthesia with labetalol in reconstructive surgery for scoliosis.
    Sum DC; Chung PC; Chen WC
    Acta Anaesthesiol Sin; 1996 Dec; 34(4):203-7. PubMed ID: 9084548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Labetalol: a new hypotensive agent in surgery of the middle ear. Peroperative hemodynamic study].
    Bertrand D; Guyon D; Maday T; Laxenaire MC
    Ann Fr Anesth Reanim; 1982; 1(4):387-92. PubMed ID: 7171135
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic changes and glucose utilization during controlled hypotensive anesthesia with labetalol and sodium nitroprusside.
    Okasha AS; el-Attar AM; el-Gamal NA
    Middle East J Anaesthesiol; 1988 Jun; 9(5):395-402. PubMed ID: 3057340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.